PUBLISHED ON: February 23, 2011 | Duration: 4 min, 19 sec
HDFC Securities VP (Institutional Research) Ranjit Kapadia analyses Ranbaxy's earnings numbers. He believes the guidance of the company is a matter of concern as it is lower than the sales guidance of calendar year 2010.
